Global Pet Antineoplastic Drug Market Growth (Status and Outlook) 2026-2032

June 2026 | 75 pages | ID: GFB04B5FAF3DEN
LP Information

Abstracts

The global Pet Antineoplastic Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Pet Antineoplastic Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Pet Antineoplastic Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Pet Antineoplastic Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Pet Antineoplastic Drug players cover Zoetis, Merck Animal Health, Virbac, Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Pet Antineoplastic Drug Industry Forecast? looks at past sales and reviews total world Pet Antineoplastic Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet Antineoplastic Drug sales for 2026 through 2032. With Pet Antineoplastic Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Antineoplastic Drug industry.

This Insight Report provides a comprehensive analysis of the global Pet Antineoplastic Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pet Antineoplastic Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pet Antineoplastic Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Antineoplastic Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Antineoplastic Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Antineoplastic Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral Drugs
• Injectable Drugs

Segmentation by Application:

• Mast Cell Tumor
• Melanoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Zoetis
• Merck Animal Health
• Virbac
• Elanco

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pet Antineoplastic Drug Market Size (2021-2032)
  2.1.2 Pet Antineoplastic Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Pet Antineoplastic Drug by Country/Region (2021, 2025 & 2032)
2.2 Pet Antineoplastic Drug Segment by Type
  2.2.1 Oral Drugs
  2.2.2 Injectable Drugs
  2.2.3 Pet Antineoplastic Drug Market Size by Type
    2.2.3.1 Pet Antineoplastic Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
2.3 Pet Antineoplastic Drug Segment by Application
  2.3.1 Mast Cell Tumor
  2.3.2 Melanoma
  2.3.3 Others
  2.3.4 Pet Antineoplastic Drug Market Size by Application
    2.3.4.1 Pet Antineoplastic Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)

3 PET ANTINEOPLASTIC DRUG MARKET SIZE BY PLAYER

3.1 Pet Antineoplastic Drug Market Size Market Share by Player
  3.1.1 Global Pet Antineoplastic Drug Revenue by Player (2021-2026)
  3.1.2 Global Pet Antineoplastic Drug Revenue Market Share by Player (2021-2026)
3.2 Global Pet Antineoplastic Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PET ANTINEOPLASTIC DRUG BY REGION

4.1 Pet Antineoplastic Drug Market Size by Region (2021-2026)
4.2 Global Pet Antineoplastic Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet Antineoplastic Drug Market Size Growth (2021-2026)
4.4 APAC Pet Antineoplastic Drug Market Size Growth (2021-2026)
4.5 Europe Pet Antineoplastic Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Pet Antineoplastic Drug Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Pet Antineoplastic Drug Market Size by Country (2021-2026)
5.2 Americas Pet Antineoplastic Drug Market Size by Type (2021-2026)
5.3 Americas Pet Antineoplastic Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pet Antineoplastic Drug Market Size by Region (2021-2026)
6.2 APAC Pet Antineoplastic Drug Market Size by Type (2021-2026)
6.3 APAC Pet Antineoplastic Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pet Antineoplastic Drug Market Size by Country (2021-2026)
7.2 Europe Pet Antineoplastic Drug Market Size by Type (2021-2026)
7.3 Europe Pet Antineoplastic Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pet Antineoplastic Drug by Region (2021-2026)
8.2 Middle East & Africa Pet Antineoplastic Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Pet Antineoplastic Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PET ANTINEOPLASTIC DRUG MARKET FORECAST

10.1 Global Pet Antineoplastic Drug Forecast by Region (2027-2032)
  10.1.1 Global Pet Antineoplastic Drug Forecast by Region (2027-2032)
  10.1.2 Americas Pet Antineoplastic Drug Forecast
  10.1.3 APAC Pet Antineoplastic Drug Forecast
  10.1.4 Europe Pet Antineoplastic Drug Forecast
  10.1.5 Middle East & Africa Pet Antineoplastic Drug Forecast
10.2 Americas Pet Antineoplastic Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Pet Antineoplastic Drug Forecast
  10.2.2 Canada Market Pet Antineoplastic Drug Forecast
  10.2.3 Mexico Market Pet Antineoplastic Drug Forecast
  10.2.4 Brazil Market Pet Antineoplastic Drug Forecast
10.3 APAC Pet Antineoplastic Drug Forecast by Region (2027-2032)
  10.3.1 China Pet Antineoplastic Drug Market Forecast
  10.3.2 Japan Market Pet Antineoplastic Drug Forecast
  10.3.3 Korea Market Pet Antineoplastic Drug Forecast
  10.3.4 Southeast Asia Market Pet Antineoplastic Drug Forecast
  10.3.5 India Market Pet Antineoplastic Drug Forecast
  10.3.6 Australia Market Pet Antineoplastic Drug Forecast
10.4 Europe Pet Antineoplastic Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Pet Antineoplastic Drug Forecast
  10.4.2 France Market Pet Antineoplastic Drug Forecast
  10.4.3 UK Market Pet Antineoplastic Drug Forecast
  10.4.4 Italy Market Pet Antineoplastic Drug Forecast
  10.4.5 Russia Market Pet Antineoplastic Drug Forecast
10.5 Middle East & Africa Pet Antineoplastic Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Pet Antineoplastic Drug Forecast
  10.5.2 South Africa Market Pet Antineoplastic Drug Forecast
  10.5.3 Israel Market Pet Antineoplastic Drug Forecast
  10.5.4 Turkey Market Pet Antineoplastic Drug Forecast
10.6 Global Pet Antineoplastic Drug Forecast by Type (2027-2032)
10.7 Global Pet Antineoplastic Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Pet Antineoplastic Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Zoetis
  11.1.1 Zoetis Company Information
  11.1.2 Zoetis Pet Antineoplastic Drug Product Offered
  11.1.3 Zoetis Pet Antineoplastic Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Zoetis Main Business Overview
  11.1.5 Zoetis Latest Developments
11.2 Merck Animal Health
  11.2.1 Merck Animal Health Company Information
  11.2.2 Merck Animal Health Pet Antineoplastic Drug Product Offered
  11.2.3 Merck Animal Health Pet Antineoplastic Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Merck Animal Health Main Business Overview
  11.2.5 Merck Animal Health Latest Developments
11.3 Virbac
  11.3.1 Virbac Company Information
  11.3.2 Virbac Pet Antineoplastic Drug Product Offered
  11.3.3 Virbac Pet Antineoplastic Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Virbac Main Business Overview
  11.3.5 Virbac Latest Developments
11.4 Elanco
  11.4.1 Elanco Company Information
  11.4.2 Elanco Pet Antineoplastic Drug Product Offered
  11.4.3 Elanco Pet Antineoplastic Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Elanco Main Business Overview
  11.4.5 Elanco Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pet Antineoplastic Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pet Antineoplastic Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Drugs
Table 4. Major Players of Injectable Drugs
Table 5. Pet Antineoplastic Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Pet Antineoplastic Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
Table 8. Pet Antineoplastic Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Pet Antineoplastic Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Pet Antineoplastic Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Pet Antineoplastic Drug Revenue Market Share by Player (2021-2026)
Table 13. Pet Antineoplastic Drug Key Players Head office and Products Offered
Table 14. Pet Antineoplastic Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pet Antineoplastic Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Pet Antineoplastic Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Pet Antineoplastic Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Pet Antineoplastic Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Pet Antineoplastic Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Pet Antineoplastic Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Pet Antineoplastic Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Pet Antineoplastic Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Pet Antineoplastic Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Pet Antineoplastic Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Pet Antineoplastic Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Pet Antineoplastic Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Pet Antineoplastic Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Pet Antineoplastic Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Pet Antineoplastic Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Pet Antineoplastic Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Pet Antineoplastic Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Pet Antineoplastic Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pet Antineoplastic Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Pet Antineoplastic Drug
Table 39. Key Market Challenges & Risks of Pet Antineoplastic Drug
Table 40. Key Industry Trends of Pet Antineoplastic Drug
Table 41. Global Pet Antineoplastic Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Pet Antineoplastic Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Pet Antineoplastic Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Pet Antineoplastic Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Zoetis Details, Company Type, Pet Antineoplastic Drug Area Served and Its Competitors
Table 46. Zoetis Pet Antineoplastic Drug Product Offered
Table 47. Zoetis Pet Antineoplastic Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Zoetis Main Business
Table 49. Zoetis Latest Developments
Table 50. Merck Animal Health Details, Company Type, Pet Antineoplastic Drug Area Served and Its Competitors
Table 51. Merck Animal Health Pet Antineoplastic Drug Product Offered
Table 52. Merck Animal Health Pet Antineoplastic Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Merck Animal Health Main Business
Table 54. Merck Animal Health Latest Developments
Table 55. Virbac Details, Company Type, Pet Antineoplastic Drug Area Served and Its Competitors
Table 56. Virbac Pet Antineoplastic Drug Product Offered
Table 57. Virbac Pet Antineoplastic Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Virbac Main Business
Table 59. Virbac Latest Developments
Table 60. Elanco Details, Company Type, Pet Antineoplastic Drug Area Served and Its Competitors
Table 61. Elanco Pet Antineoplastic Drug Product Offered
Table 62. Elanco Pet Antineoplastic Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Elanco Main Business
Table 64. Elanco Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Pet Antineoplastic Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pet Antineoplastic Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pet Antineoplastic Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pet Antineoplastic Drug Sales Market Share by Country/Region (2025)
Figure 8. Pet Antineoplastic Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pet Antineoplastic Drug Market Size Market Share by Type in 2025
Figure 10. Pet Antineoplastic Drug in Mast Cell Tumor
Figure 11. Global Pet Antineoplastic Drug Market: Mast Cell Tumor (2021-2026) & ($ millions)
Figure 12. Pet Antineoplastic Drug in Melanoma
Figure 13. Global Pet Antineoplastic Drug Market: Melanoma (2021-2026) & ($ millions)
Figure 14. Pet Antineoplastic Drug in Others
Figure 15. Global Pet Antineoplastic Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Pet Antineoplastic Drug Market Size Market Share by Application in 2025
Figure 17. Global Pet Antineoplastic Drug Revenue Market Share by Player in 2025
Figure 18. Global Pet Antineoplastic Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pet Antineoplastic Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Pet Antineoplastic Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Pet Antineoplastic Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pet Antineoplastic Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Pet Antineoplastic Drug Value Market Share by Country in 2025
Figure 24. United States Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pet Antineoplastic Drug Market Size Market Share by Region in 2025
Figure 29. APAC Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pet Antineoplastic Drug Market Size Market Share by Country in 2025
Figure 38. Europe Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pet Antineoplastic Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pet Antineoplastic Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pet Antineoplastic Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pet Antineoplastic Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 61. China Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 65. India Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 68. France Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Pet Antineoplastic Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pet Antineoplastic Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pet Antineoplastic Drug Market Size 2027-2032 ($ millions)